CardiaCare Announces Licensing and Distribution Agreement to Commercialize its Digital Neuromodulation Wearable for Non-invasive Atrial Fibrillation Treatment ...Middle East

REHOVOT, Israel, Dec. 15, 2022 /PRNewswire/ -- CardiaCare, a clinical stage digital therapeutic company developing the world's first non-invasive, personalized neuromodulation wearable for atrial fibrillation treatment, announced today the execution of a strategic licensing agreement with...

Hence then, the article about cardiacare announces licensing and distribution agreement to commercialize its digital neuromodulation wearable for non invasive atrial fibrillation treatment was published today ( Thursday 15/12/2022 - 11:45 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CardiaCare Announces Licensing and Distribution Agreement to Commercialize its Digital Neuromodulation Wearable for Non-invasive Atrial Fibrillation Treatment )

Also on site :

• Trump endorses Steven Hilton in California governor's race
• 10 Years Ago Today, Country Music Legend Died on His 79th Birthday After Eerily Predicting He Would
• This 1954 Film Ranked as Alfred Hitchcock's No. 1 'Masterpiece'